Antibiotics

AMR Action Fund will support biotechs working on later stages of clinical development, with the aim of delivering 2 - 4 new antibiotics by 2030

Low profitability of antibiotics means fight against drug resistance relies on a handful of companies

Study raises concerns that new antibiotics will do little to solve the resistance problem if the drugs are used inappropriately once they are introduced

As the EU marks the 10th European Antibiotic Awareness Day and the latest data shows the threat continuing to grow, a review of progress in halting antimicrobial resistance says governments need to act decisively on control measures

Developing new antibiotics, from the first idea to proof of concept. The German-Australian iCAIR project brings together researchers from Fraunhofer ITEM, the MHH in Hannover and Griffith University in Australia.

As WHO warns the antibiotics pipeline does not address the threat of bacterial resistance, the EU must step up and do more to galvanise R&D, accelerate innovation and help shape a coordinated global response to the impending crisis